Colonoscopy and its complications across a Canadian regional health authority - 23/08/11
Winnipeg, Manitoba, Canada
Abstract |
Background |
Defining the complication rate of endoscopy performed across an entire city will capture usual as opposed to referral center data.
Objective |
Our purpose was to evaluate the current practice of colonoscopy and complications associated with lower GI endoscopy in usual clinical practice.
Design |
All admissions within 30 days of an outpatient lower GI endoscopy at any of the 6 adult-care Winnipeg hospitals were identified. This includes endoscopy for both complex and routine patients. A chart audit of all cases with potential complications was performed.
Results |
A total of 24,509 outpatient lower GI endoscopies for adults were performed at the 6 hospitals over the 2 study years (April 1, 2004, to March 31, 2006). There were 303 admissions with potential complications. The colonoscopy completion rate was 65% (72% for gastroenterologists vs 59% for general surgeons, P < .005). Quality of bowel preparation and nature of polyps were often not documented. The overall rate of complications was 2.9/1000 procedures; the perforation rate after polypectomy was 1.8/1000; and the postpolypectomy bleeding rate was 6.4/1000. Most (67%) complications were recognized after discharge for the index procedure. The complication rate was highest for the endoscopists performing fewer than 200 procedures per year (5.4/1000 vs 2.7/1000 for the rest, P = .02, relative risk 2 [95% CI, 1.1-3.7]).
Limitations |
Chart audit was limited to cases requiring admission within 30 days of the index procedure.
Conclusions |
The overall complication rate after lower GI endoscopy in usual clinical practice in Winnipeg is comparable to that previously reported. A higher complication rate after endoscopy by low-volume endoscopists needs to be further evaluated. The reporting of endoscopy must be standardized to enhance outcomes interpretation.
Le texte complet de cet article est disponible en PDF.Abbreviations : ASGE, DSS, MHHL, NCCRT, WRHA
Plan
| DISCLOSURE: The following authors disclosed financial relationships relevant to this publication: H. Singh is supported in part by a Dr F. W. Du Val Clinical Research Professorship Award. C. N. Bernstein is supported in part by a Research Scientist Award of the Crohn’s and Colitis Foundation of Canada. All other authors disclosed no financial relationships relevant to this publication. |
|
| If you want to chat with an author of this article, you may contact him at [email protected]. |
Vol 69 - N° 3P2
P. 665-671 - mars 2009 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
